Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men

Journal of Infectious Diseases

Volumn 187, Issue 1, 2003, Pages 12-18

  Biggar, Robert J ^a   Engels, Eric A ^a   Whitby, Denise ^b   Kedes, Dean H ^c   Goedert, James J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPITOPE;

ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOFLUORESCENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LONGITUDINAL STUDIES; MALE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROSPECTIVE STUDIES; SARCOMA, KAPOSI; VIRAL PROTEINS; VIRUS LATENCY;

EID: 0037219597     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/345866     Document Type: Article

References (25)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2:925-8.
3. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348:858-61.
4. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2:918-24.
5. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-8.
6. Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999; 340:1863-71.
7. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 1998; 178:304-9.
8. Gambus G, Bourboulia D, Esteve A, et al. Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS 2001; 15:1167-74.
9. Schatz O, Monini P, Bugarini R, et al. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: Multicentre study with multipte and novel assays. J Med Virol 2001; 65:123-32.
10. Melbye M, Cook PM, Hjalgrim H, et al. Factors for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998; 77:543-8.
11. O'Brien TR, Kedes D, Ganem DD, et al. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: Rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999; 180:1010-7.
12. Quilivan EB, Wang RZ, Stewart PW, et al. Longitudinal sero-reactivity to human herpesvirus 8 in the Swiss HIV cohort 4.7 years before Kaposi's sarcoma. J Med Virol 2001; 64:157-66.
13. Renwick T, Halaby GJ, Weverling NH, et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998; 12:2481-8.
14. Goudsmit J, Renwick N, Dukers NH, et al. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): Analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci USA 2000; 97:4838-43.
15. Viviano E, Vitale F, Ajello F, et al. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and -negative individuais in Sicily. AIDS 1997; 11:607-12.
16. Ariyoshi K, Schim van der Loeff M, Cook P, et al. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998; 1:193-9.
17. Engels EA, Whitby D, Goebel PB, et al. Identifying human herpesvirus 8 infection: Performance characteristics of serologic assays. J Acquir Immune Defic Syndr 2000; 23:346-354.
18. Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343:1369-77.
19. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuais and progression to Kaposi's sarcoma. Lancet 1995; 346:799-802.
20. Boshoff C, Weiss RA. Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res 1998; 75:57-86.
21. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10:175-80.
22. Goedert JJ, Sarngadharan MG, Biggar RJ, et al. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet 1984; 2:711-6.
23. Goedert JJ, Biggar RJ, Winn DM, et al. Decreased helper T-lymphocytes in homosexual men. II. Sexual practices. Am J Epidemiol 1985; 121:637-44.
24. Jacobson LP, Jenkins FJ, Springer G, et al. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 2000; 181:1940-9.
25. Biggar RJ, Pandey JP, Henle W, Nkrumah FK, Levine PH. Humoral immune responses to Epstein-Barr virus antigen and immunoglobulin allotypes in African Burkitt's lymphoma. Int J Cancer 1984; 33:577-80.